Stay updated on KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.

Latest updates to the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.6.6 was added and Revision: v3.6.5 was removed, indicating the page has been updated to a new revision. The update represents a version change of the page rather than a change to the study details.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now shows Revision: v3.6.5 in place of Revision: v3.6.4, signaling an update to the page's version.SummaryDifference0.1%

- Check42 days agoChange DetectedThe site version updated from v3.6.3 to v3.6.4, indicating a behind-the-scenes deployment of improvements; no visible changes to the study details or layout are described.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page's revision label updated from v3.6.2 to v3.6.3, representing a version bump of the page template or site framework.SummaryDifference0.1%

- Check70 days agoChange DetectedThe revision tag on the page updated from v3.6.0 to v3.6.2, signaling a newer version of the page content. This update serves for internal tracking of page versions rather than altering displayed study information.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded new help/navigation sections: How to Read a Study Record, Common Questions, and How to Join a Study, along with a recruitment note saying No longer looking for participants. Revision: v3.6.0 was introduced and the Intervention/Treatment header formatting was adjusted from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.4%

Stay in the know with updates to KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.